These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 35822939)

  • 41. Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics.
    Thakur S; Dhapola R; Sarma P; Medhi B; Reddy DH
    Inflammation; 2023 Feb; 46(1):1-17. PubMed ID: 35986874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DW14006 as a direct AMPKα1 activator improves pathology of AD model mice by regulating microglial phagocytosis and neuroinflammation.
    Lv J; Wang W; Zhu X; Xu X; Yan Q; Lu J; Shi X; Wang Z; Zhou J; Huang X; Wang J; Duan W; Shen X
    Brain Behav Immun; 2020 Nov; 90():55-69. PubMed ID: 32739363
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microglia in Alzheimer's Disease: A Favorable Cellular Target to Ameliorate Alzheimer's Pathogenesis.
    Sumsuzzman DM; Uddin MS; Kabir MT; Hasana S; Perveen A; Alanazi IS; Albadrani GM; Abdel-Daim MM; Ashraf GM
    Mediators Inflamm; 2022; 2022():6052932. PubMed ID: 35693110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanism of TREM2/DAP12 complex affecting β-amyloid plaque deposition in Alzheimer's disease modeled mice through mediating inflammatory response.
    Cui X; Qiao J; Liu S; Wu M; Gu W
    Brain Res Bull; 2021 Jan; 166():21-28. PubMed ID: 33053435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia.
    Hüttenrauch M; Ogorek I; Klafki H; Otto M; Stadelmann C; Weggen S; Wiltfang J; Wirths O
    Acta Neuropathol Commun; 2018 Oct; 6(1):108. PubMed ID: 30340518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets.
    Cai Y; Liu J; Wang B; Sun M; Yang H
    Front Immunol; 2022; 13():856376. PubMed ID: 35558075
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TSPO deficiency accelerates amyloid pathology and neuroinflammation by impairing microglial phagocytosis.
    Zhang H; Wang H; Gao F; Yang J; Xu Y; Fu Y; Cai M; Zhang X; Yang Q; Tong K; Hu Y; Chen H; Ma C; He W; Zhang J
    Neurobiol Aging; 2021 Oct; 106():292-303. PubMed ID: 34340010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies.
    Casali BT; MacPherson KP; Reed-Geaghan EG; Landreth GE
    Neurobiol Dis; 2020 Aug; 142():104956. PubMed ID: 32479996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease.
    Pey P; Pearce RK; Kalaitzakis ME; Griffin WS; Gentleman SM
    Acta Neuropathol Commun; 2014 Feb; 2():21. PubMed ID: 24528486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microglial Endocannabinoid Signalling in AD.
    Scipioni L; Ciaramellano F; Carnicelli V; Leuti A; Lizzi AR; De Dominicis N; Oddi S; Maccarrone M
    Cells; 2022 Apr; 11(7):. PubMed ID: 35406803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The age-related microglial transformation in Alzheimer's disease pathogenesis.
    Yuan C; Aierken A; Xie Z; Li N; Zhao J; Qing H
    Neurobiol Aging; 2020 Aug; 92():82-91. PubMed ID: 32408056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microglia actions in Alzheimer’s disease.
    Prokop S; Miller KR; Heppner FL
    Acta Neuropathol; 2013 Oct; 126(4):461-77. PubMed ID: 24224195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipopolysaccharide-Induced Exosomal miR-146a Is Involved in Altered Expression of Alzheimer's Risk Genes Via Suppression of TLR4 Signaling.
    Yang J; Malone F; Go M; Kou J; Lim JE; Caughey RC; Fukuchi KI
    J Mol Neurosci; 2021 Jun; 71(6):1245-1255. PubMed ID: 33185814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microglia and amyloid plaque formation in Alzheimer's disease - Evidence, possible mechanisms, and future challenges.
    Fruhwürth S; Zetterberg H; Paludan SR
    J Neuroimmunol; 2024 May; 390():578342. PubMed ID: 38640827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.
    Fan Z; Okello AA; Brooks DJ; Edison P
    Brain; 2015 Dec; 138(Pt 12):3685-98. PubMed ID: 26510952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Manipulation of microglial activity as a therapy for Alzheimer's disease.
    Tan B; Choi RH; Chin TJ; Kaur C; Ling EA
    Front Biosci (Schol Ed); 2012 Jun; 4(4):1402-12. PubMed ID: 22652882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Roles of microglia in Alzheimer's disease and impact of new findings on microglial heterogeneity as a target for therapeutic intervention.
    Takata K; Ginhoux F; Shimohama S
    Biochem Pharmacol; 2021 Oct; 192():114754. PubMed ID: 34480881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD11a expression distinguishes infiltrating myeloid cells from plaque-associated microglia in Alzheimer's disease.
    Shukla AK; McIntyre LL; Marsh SE; Schneider CA; Hoover EM; Walsh CM; Lodoen MB; Blurton-Jones M; Inlay MA
    Glia; 2019 May; 67(5):844-856. PubMed ID: 30588668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microglia in Alzheimer's disease.
    Sarlus H; Heneka MT
    J Clin Invest; 2017 Sep; 127(9):3240-3249. PubMed ID: 28862638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner.
    Wong MY; Lewis M; Doherty JJ; Shi Y; Cashikar AG; Amelianchik A; Tymchuk S; Sullivan PM; Qian M; Covey DF; Petsko GA; Holtzman DM; Paul SM; Luo W
    J Neuroinflammation; 2020 Jun; 17(1):192. PubMed ID: 32552741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.